Thank you for your interest in the recent webinar, Critical Path for Rare Neurodegenerative Diseases (CP-RND): An Introduction to the Patient Community. We hope the presentation and conversation with our panelists offered additional insight on the public-private partnership and how we intend to impact drug development for rare neurodegenerative diseases, including ALS. We will continue to have ongoing discussions and webinars updating the patient community on CP-RND’s progress.
